{"name": "ProCertus BioPharm",
 "permalink": "procertus-biopharm",
 "crunchbase_url": "http://www.crunchbase.com/company/procertus-biopharm",
 "homepage_url": "http://www.procertus.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "fahl@procertus.com",
 "phone_number": "(608) 277-7950",
 "description": "",
 "created_at": "Wed Apr 06 02:28:18 UTC 2011",
 "updated_at": "Wed Apr 06 02:28:17 UTC 2011",
 "overview": "\u003Cp\u003EProCertus BioPharm, Inc., an oncology-based pharmaceutical company, develops therapeutics to protect cancer patients from the side effects of radiotherapy and chemotherapy in the United States. Its products include ProDermaCel that protects cancer patients from chemotherapy- and radiotherapy-induced alopecia; DermX, which prevents radiotherapy-induced dermatitis; and OralX that provides protection against chemotherapy- and radiotherapy- induced oral mucositis. ProCertus BioPharm, Inc. was founded in 1997 and is based in Madison, Wisconsin.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       40],
      "assets/images/resized/0012/9405/129405v1-max-150x150.png"],
     [[224,
       61],
      "assets/images/resized/0012/9405/129405v1-max-250x250.png"],
     [[224,
       61],
      "assets/images/resized/0012/9405/129405v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Paul",
      "last_name": "M. Weiss",
      "permalink": "paul-m-weiss",
      "image": null}},
   {"is_past": false,
    "title": "Chairman, and Chief Scientific Officer",
    "person":
     {"first_name": "William",
      "last_name": "E. Fahl",
      "permalink": "william-e-fahl",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1.7M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.procertus.com/procertus_pr_040411_01.pdf",
    "source_description": "ProCertus BioPharm secures $1.7 million in financing",
    "raised_amount": 1700000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 4,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "510 Charmany Drive",
    "address2": "Suite 175 B",
    "zip_code": "53719",
    "city": "Madison",
    "state_code": "WI",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}